TNFSF10 and neoplasm: Although many human tumor cell lines are sensitive to TRAIL agonist-mediated apoptosis and are being evaluated in clinic trials [12, 13], many tumors including HCC and gastric cancer are still resistant to TRAIL-induced apoptosis.